MarketInOut Stock Screener Log In | Sign Up
 

Sana Biotechnology Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/23/2026
Sana Biotechnology Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization682.45 mln
Float187 mln
Earnings Date11/05/2026

Piotroski F-Score

1 / 9
Very weak

Relative Strength

16 / 100
Significantly lagging

Debt / Equity

0.48
Low leverage

ROE

-141
Deeply negative

ROA

-52.20
Deeply negative

Business Description

Sana Biotechnology is a Seattle-based company working to treat serious diseases by engineering human cells and using them as medicines. Its main focus areas include type 1 diabetes, autoimmune diseases, and cancer, with several treatments currently in clinical and preclinical development. The company works with partners such as Beam Therapeutics and Harvard College to access cutting-edge technologies that help make its cell therapies more effective and compatible with a wider range of patients.

Key Fundamentals

EPS-0.76
ROE-141
ROIC-55.70
ROA-52.20
EBITDA, mln-201
EV / EBITDA-3.83
EV / EBIT-3.63

Quote Details

Last 2.33
Change -0.04 (-1.69%)
Open 2.35
Volume 1,707,913
Turnover 3,979,437
Average Volume 3,256,001

Financial Ratios

Leverage Ratio2.79
Current Ratio1.38
Price / Book5.61
Debt / Equity0.48

Financial Strength

Piotroski F-Score 1 / 9
Short Ratio10.10
Short % of Float21.83

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 2.64% 82 / 100   
1 Month -21.28% 17 / 100   
2 Months -25.8% 19 / 100   
6 Months -29.18% 21 / 100   
1 Year -57.64% 15 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog